Resources

Sharing knowledge about promising practices and their sustainable implementation is vital to ending the opioid and drug overdose crisis. Our publications and webinars include the recommendations of experts and the perspectives of those on the frontlines.

COVID-19 Response

FORE Opinion Letter: Prescribing Buprenorphine During a Public Health Emergency

April 1, 2020
Legal analysis of four hypothetical scenarios for prescribing buprenorphine for opioid use disorder in the United States during th...

COVID-19 Response

HHS/OCR: Enforcement Discretion for Telehealth Remote Communications During COVID-19

March 17, 2020
The Office for Civil Rights (OCR) will exercise enforcement discretion and will waive potential penalties for HIPAA violations aga...

COVID-19 Response

DEA: Expanded MOUD Telemedicine Guidance

March 17, 2020
The Drug Enforcement Administration (DEA) has provided further guidance on the expanded use of telemedicine for medications for op...

COVID-19 Response

SAMHSA: Opioid Treatment Program (OTP) Guidance

March 17, 2020
The Substance Abuse and Mental Health Services Administration (SAMHSA) expands previous guidance to provide increased flexibility ...

COVID-19 Response

SAMHSA: COVID-19 Guidance for Opioid Treatment Programs

March 16, 2020
The Substance Abuse and Mental Health Services Administration (SAMHSA) provides guidance on pharmacotherapy for opioid use disorde...

COVID-19 Response

NIDA: Potential Implications for Individuals with Substance Use Disorders

March 12, 2020
Nora Volkow, M.D., Director of the National Institute on Drug Abuse (NIDA), highlights the added risks that populations with subst...